Gregory Albert
Delray Beach, FLNPI 1871669069
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (42.3%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Microaire Surgical Instruments LLC accounts for 64.1% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2019 at $19,363 and has fallen 97.7% since, to $440 in 2025.
Across 169 payments — averaging $271.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Microaire Surgical Instruments LLC$29K
- AbbVie$13K
- Lumenis BE Inc$2K
- Sientra, Inc.$460
- TELA Bio, Inc.$437
- Merz North America, Inc.$374
- plus $625 from 12 others
What the payments were for
- Consulting fees$19,41542%
- Speaking & faculty fees$13,90030%
- Travel & lodging$3,1817%
- Food & beverage$6,64314%
- Education$580%
- Gifts$2,7006%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Microaire Surgical Instruments LLC | 16 | $29,402 |
| AbbVie(2 entities) | 103 | $12,970 |
| Lumenis BE Inc | 1 | $1,630 |
| Sientra, Inc. | 11 | $460 |
| TELA Bio, Inc. | 10 | $437 |
| Merz North America, Inc. | 3 | $374 |
| Davol Inc. | 3 | $166 |
| Galderma Laboratories, L.p. | 7 | $119 |
| Medtronic | 2 | $61 |
| Integra Lifesciences Corporation | 2 | $59 |
| Kowa Pharmaceuticals America, Inc. | 3 | $58 |
| BD | 1 | $34 |
| Apyx Medical Corporation | 2 | $31 |
| Vertical Pharmaceuticals, LLC | 1 | $29 |
| Vertex | 1 | $19 |
| Coopersurgical, Inc. | 1 | $19 |
| KCI USA, Inc. | 1 | $16 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENDOTINE$14,114
- BOTOX$4,206
- BOTOX COSMETIC$3,784
- NATRELLE$2,831
- M22$1,630
- XEOMIN$374
- ASCLERA$374
- SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT$142
- NATRELLE SALINE-FILLED BREAST IMPLANTS$141
- OviTex 2S$124
- Phasix Mesh$107
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 22 | $370 |
| Methylprednisolone | 39 | $264 |
| Cephalexin | 35 | $155 |
| Ondansetron OdtOndansetron | 25 | $140 |
| ErythromycinErythromycin Base | 14 | $113 |
| Clindamycin Hcl | 18 | $113 |
| Zolpidem Tartrate | 17 | $100 |
| ValacyclovirValacyclovir Hcl | 12 | $96 |
| Diazepam | 15 | $43 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.